New injection could ease arthritis pain
NCT ID NCT03245008
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a drug called MT-5547 (fasinumab) in 626 Japanese adults with moderate to severe osteoarthritis pain in the knee or hip. Participants received either the drug or a placebo injection for 16 weeks. The goal was to see if the drug reduces pain and improves daily function better than a placebo.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MT-5547 (fasinumab) injection
What this could lead to
If successful, this could provide a new treatment option for people with osteoarthritis who have moderate to severe pain.
What could go wrong
This is an early-to-mid-stage trial, so results may not confirm long-term safety or effectiveness. The drug may cause side effects or not work better than a placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS OF THE KNEE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site
Aichi, Japan
-
Investigational Site
Aomori, Japan
-
Investigational Site
Chiba, Japan
-
Investigational Site
Ehime, Japan
-
Investigational Site
Fukui, Japan
-
Investigational Site
Fukuoka, Japan
-
Investigational Site
Fukushima, Japan
-
Investigational Site
Gunma, Japan
-
Investigational Site
Hiroshima, Japan
-
Investigational Site
Hokkaido, Japan
-
Investigational Site
Hyōgo, Japan
-
Investigational Site
Ibaraki, Japan
-
Investigational Site
Kagoshima, Japan
-
Investigational Site
Kanagawa, Japan
-
Investigational Site
Kumamoto, Japan
-
Investigational Site
Kyoto, Japan
-
Investigational Site
Mie, Japan
-
Investigational Site
Miyagi, Japan
-
Investigational Site
Miyazaki, Japan
-
Investigational Site
Osaka, Japan
-
Investigational Site
Ōita, Japan
-
Investigational Site
Saitama, Japan
-
Investigational Site
Shiga, Japan
-
Investigational Site
Shizuoka, Japan
-
Investigational Site
Tokyo, Japan
-
Investigational Site
Yamagata, Japan
-
Investigational Site
Yamaguchi, Japan